RBC Capital Downgrades Auxilium Pharmaceuticals (AUXL) to Sector Perform
Tweet Send to a Friend
RBC Capital downgraded Auxilium Pharmaceuticals (NASDAQ: AUXL) from Outperform to Sector Perform with a price target of $32.00 (from $28.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
